CTA-verified high-risk plaque predicted acute coronary syndrome, occurring in 16.3% of HRP(+) patients versus 1.4% of HRP(-) patients over a mean follow-up of 3.9 years.
Cohort (n=3,158)
Does plaque characterization by coronary CTA predict the mid-term likelihood of acute coronary syndrome in patients undergoing CTA?
3,158 patients undergoing coronary computed tomography angiography (CTA), with a subset of 449 patients undergoing serial CTA.
Plaque characterization by CTA (evaluation of high-risk plaque [HRP], significant stenosis [SS] ≥70%, and plaque progression [PP] on serial CTA)
Patients without high-risk plaque, without significant stenosis, or without plaque progression
Fatal and nonfatal acute coronary syndrome (ACS)hard clinical
CTA-verified high-risk plaque and plaque progression are strong independent predictors of mid-term ACS, although a similar absolute number of ACS events arise from non-high-risk plaques due to their higher overall prevalence.
Absolute Event Rate: 16.3% vs 1.4%
BACKGROUND Coronary computed tomography angiography (CTA)-verified positive remodeling and low attenuation plaques are considered morphological characteristics of high-risk plaque (HRP) and predict short-term risk of acute coronary syndrome (ACS). OBJECTIVES This study evaluated whether plaque characteristics by CTA predict mid-term likelihood of ACS. METHODS The presence of HRP and significant stenosis (SS) of ≥70% were evaluated in 3,158 patients undergoing CTA. Serial CTA was performed in 449 patients, and plaque progression (PP) was evaluated. Outcomes (fatal and nonfatal ACS) were recorded during follow-up (mean 3.9 ± 2.4 years). RESULTS ACS occurred in 88 (2.8%) patients: 48 (16.3%) of 294 HRP(+) and 40 (1.4%) of 2,864 HRP(-) patients. ACS was also significantly more frequent in SS(+) (36 of 659; 5.5%) than SS(-) patients (52 of 2,499; 2.1%). HRP(+)/SS(+) (19%) and HRP(+)/SS(-) (15%) had higher rates of ACS compared with no-plaque patients (0.6%). Although ACS incidence was relatively low in HRP(-) patients, the cumulative number of patients with ACS developing from HRP(-) lesions (n = 43) was similar to ACS patients with HRP(+) lesions (n = 45). In patients with serial CTA, PP also was an independent predictor of ACS, with HRP (27%; p < 0.0001) and without HRP (10%) compared with HRP(-)/PP(-) patients (0.3%). CONCLUSIONS CTA-verified HRP was an independent predictor of ACS. However, the cumulative number of ACS patients with HRP(-) was similar to patients with HRP(+). Additionally, plaque progression detected by serial CTA was an independent predictor of ACS.
Building similarity graph...
Analyzing shared references across papers
Loading...
Sadako Motoyama
Fujita Health University
Hajime Ito
Fujita Health University
Masayoshi Sarai
Fujita Health University
Journal of the American College of Cardiology
Emory University
Icahn School of Medicine at Mount Sinai
Fujita Health University
Building similarity graph...
Analyzing shared references across papers
Loading...
Motoyama et al. (Wed,) conducted a cohort in Patients undergoing coronary computed tomography angiography (n=3,158). High-risk plaque (HRP) by CTA vs. Absence of high-risk plaque (HRP(-)) was evaluated on Fatal and nonfatal acute coronary syndrome (ACS). CTA-verified high-risk plaque predicted acute coronary syndrome, occurring in 16.3% of HRP(+) patients versus 1.4% of HRP(-) patients over a mean follow-up of 3.9 years.
synapsesocial.com/papers/69e6eca292d553e56bf21f5f — DOI: https://doi.org/10.1016/j.jacc.2015.05.069
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: